ID27576A - Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun - Google Patents
Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimunInfo
- Publication number
- ID27576A ID27576A IDW20002433A ID20002433A ID27576A ID 27576 A ID27576 A ID 27576A ID W20002433 A IDW20002433 A ID W20002433A ID 20002433 A ID20002433 A ID 20002433A ID 27576 A ID27576 A ID 27576A
- Authority
- ID
- Indonesia
- Prior art keywords
- cycosporine
- autoimun
- treatment
- disease diseases
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9811854.0A GB9811854D0 (en) | 1998-06-02 | 1998-06-02 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ID27576A true ID27576A (id) | 2001-04-12 |
Family
ID=10833083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20002433A ID27576A (id) | 1998-06-02 | 1999-05-31 | Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1082130A1 (no) |
JP (2) | JP4523154B2 (no) |
KR (1) | KR20010043969A (no) |
CN (1) | CN1304315A (no) |
AU (1) | AU750422B2 (no) |
BR (1) | BR9910860A (no) |
CA (1) | CA2333315A1 (no) |
GB (1) | GB9811854D0 (no) |
HU (1) | HUP0102142A3 (no) |
ID (1) | ID27576A (no) |
IL (1) | IL139589A0 (no) |
NO (1) | NO20006113L (no) |
PL (1) | PL344451A1 (no) |
SK (1) | SK18142000A3 (no) |
TW (2) | TWI250021B (no) |
WO (1) | WO1999062540A1 (no) |
ZA (1) | ZA200006464B (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2243314T3 (es) | 1999-10-27 | 2005-12-01 | Alexandra Lucas | Composiciones para la prevencion y el tratamiento del rechazo de trasplantes. |
AU9157901A (en) * | 2000-09-29 | 2002-04-08 | Z Robert Zhong | Methods of treating inflammatory and immune reactions and compositions therefor |
GB0320638D0 (en) * | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
JP2007532507A (ja) * | 2004-04-08 | 2007-11-15 | ノバルティス アクチエンゲゼルシャフト | 脳虚血ならびに脳および脊髄傷害の処置のためのサイクロスポリンの使用 |
MX2007000503A (es) | 2004-07-14 | 2007-03-08 | Novartis Ag | Uso de una combinacion de ciclosporina e interferon pegilado para el tratamiento de hepatitis c(hcv). |
EP1793844B1 (en) * | 2004-10-01 | 2010-12-08 | Debiopharm S.A. | Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection |
US7285530B2 (en) | 2004-10-21 | 2007-10-23 | Viron Therapeutics, Inc. | Use of SERP-1 as an antiplatelet agent |
CN101084005A (zh) * | 2004-12-23 | 2007-12-05 | 诺瓦提斯公司 | 用于黄病毒科治疗的化合物 |
EP1830871A1 (en) * | 2004-12-23 | 2007-09-12 | Novartis AG | Compositions for hcv treatment |
EP1893211B1 (en) * | 2005-06-17 | 2011-09-14 | Novartis AG | Use of sanglifehrin in hcv |
JP2007112775A (ja) * | 2005-10-24 | 2007-05-10 | Hamamatsu Univ School Of Medicine | サイトメガロウイルス感染の処置におけるシクロスポリン類の使用 |
WO2009148615A1 (en) * | 2008-06-06 | 2009-12-10 | Scynexis, Inc. | Cyclosporin analogs and their use in the treatment of hcv infections |
CA2724523A1 (en) * | 2008-06-06 | 2010-01-07 | Scynexis, Inc. | Novel macrocyclic peptides |
AU2009334790B2 (en) | 2008-12-31 | 2016-09-08 | Scynexis, Inc. | Derivatives of cyclosporin A |
CA2782898A1 (en) * | 2009-12-09 | 2011-06-16 | Scynexis, Inc. | Novel cyclic peptides |
EP2900684A2 (en) | 2012-09-29 | 2015-08-05 | Novartis AG | Cyclic peptides and use as medicines |
WO2014063147A1 (en) * | 2012-10-19 | 2014-04-24 | Scynexis, Inc. | New antiviral macrocycles |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0484281T4 (da) * | 1990-11-02 | 2001-02-05 | Novartis Ag | Cyclosporiner |
US6124453A (en) * | 1995-07-04 | 2000-09-26 | Novartis Ag | Macrolides |
AR006514A1 (es) * | 1995-07-04 | 1999-09-08 | Sandoz Ag | Un macrolido, sus usos, un proceso para producirlo, un aislado biologicamente puro capaz de producirlo, y una composicion farmaceutica quelo comprende |
CZ288631B6 (cs) * | 1996-01-18 | 2001-08-15 | Galena, A. S. | Léčivé přípravky s obsahem cyklosporinu |
CZ288739B6 (cs) * | 1996-08-01 | 2001-08-15 | Galena, A. S. | Cyklosporin obsahující léčivé přípravky |
-
1998
- 1998-06-02 GB GBGB9811854.0A patent/GB9811854D0/en not_active Ceased
-
1999
- 1999-05-31 AU AU43724/99A patent/AU750422B2/en not_active Ceased
- 1999-05-31 WO PCT/EP1999/003770 patent/WO1999062540A1/en not_active Application Discontinuation
- 1999-05-31 ID IDW20002433A patent/ID27576A/id unknown
- 1999-05-31 EP EP99926489A patent/EP1082130A1/en not_active Withdrawn
- 1999-05-31 SK SK1814-2000A patent/SK18142000A3/sk unknown
- 1999-05-31 CA CA002333315A patent/CA2333315A1/en not_active Abandoned
- 1999-05-31 HU HU0102142A patent/HUP0102142A3/hu unknown
- 1999-05-31 CN CN99806904A patent/CN1304315A/zh active Pending
- 1999-05-31 IL IL13958999A patent/IL139589A0/xx unknown
- 1999-05-31 BR BR9910860-7A patent/BR9910860A/pt not_active IP Right Cessation
- 1999-05-31 KR KR1020007013585A patent/KR20010043969A/ko not_active Application Discontinuation
- 1999-05-31 PL PL99344451A patent/PL344451A1/xx not_active Application Discontinuation
- 1999-05-31 JP JP2000551796A patent/JP4523154B2/ja not_active Expired - Fee Related
- 1999-06-01 TW TW094110378A patent/TWI250021B/zh not_active IP Right Cessation
- 1999-06-01 TW TW088109078A patent/TWI250022B/zh not_active IP Right Cessation
-
2000
- 2000-11-09 ZA ZA200006464A patent/ZA200006464B/en unknown
- 2000-12-01 NO NO20006113A patent/NO20006113L/no not_active Application Discontinuation
-
2009
- 2009-11-04 JP JP2009252882A patent/JP2010059177A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
TWI250022B (en) | 2006-03-01 |
WO1999062540A1 (en) | 1999-12-09 |
AU4372499A (en) | 1999-12-20 |
JP2010059177A (ja) | 2010-03-18 |
JP2002516873A (ja) | 2002-06-11 |
SK18142000A3 (sk) | 2001-06-11 |
JP4523154B2 (ja) | 2010-08-11 |
TW200522975A (en) | 2005-07-16 |
NO20006113D0 (no) | 2000-12-01 |
TWI250021B (en) | 2006-03-01 |
HUP0102142A3 (en) | 2001-12-28 |
PL344451A1 (en) | 2001-11-05 |
KR20010043969A (ko) | 2001-05-25 |
NO20006113L (no) | 2001-01-25 |
GB9811854D0 (en) | 1998-07-29 |
AU750422B2 (en) | 2002-07-18 |
ZA200006464B (en) | 2002-03-11 |
EP1082130A1 (en) | 2001-03-14 |
CA2333315A1 (en) | 1999-12-09 |
IL139589A0 (en) | 2002-02-10 |
HUP0102142A2 (hu) | 2001-11-28 |
BR9910860A (pt) | 2001-03-06 |
CN1304315A (zh) | 2001-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2018020I1 (el) | Θεραπεια της νοσου ρομρε | |
FIU20060389U0 (fi) | Luusairauksien hoito | |
PT1083889E (pt) | Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas | |
ATE472325T1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
NO994014D0 (no) | Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer | |
PT1028954E (pt) | Imidazoles substituidos uteis no tratamento de doencas inflamatorias | |
DK1031346T3 (da) | Ikke-invasiv vaccination gennem huden | |
EE04156B1 (et) | Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks | |
EE200300214A (et) | Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks | |
DE69918687D1 (de) | 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen | |
ID27576A (id) | Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun | |
IS6966A (is) | Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
NO20005179D0 (no) | Medikament behandling | |
IS6967A (is) | Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
ATE258035T1 (de) | Wegwerfartikel für menschliche fäkalien | |
ITMI20001216A0 (it) | Impiego dell'aloe-emodin nel trattamento di patologie neoplastiche diorigine neuroectodermica | |
ID30458A (id) | Osanetan dalam pengobatan gangguan jiwa | |
PT1200447E (pt) | Oxazinocarbazoles para o tratamento de doencas do snc | |
NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer | |
NO20010044L (no) | Anvendelse av texafyriner i makrofag-medierte sykdommer | |
EP1322778A4 (en) | APPLICATION OF CYR61 IN THE TREATMENT AND DIAGNOSIS OF HUMAN UTERUS MYOMENIC | |
EP1107778A4 (en) | TREATMENT OF DISEASE CONDITIONS | |
GB9908059D0 (en) | Diagnosis and treatment of diseases | |
DE69813354T2 (de) | Mittel zur Behandlung von Herzkrankheiten | |
NO20030762D0 (no) | Forbedret spesifisitet i behandling av sykdommer |